Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News BioRestorative Therapies Inc BRTX

Healthcare Biotechnology
BioRestorative Therapies, Inc. is engaged in developing therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The Company has two core programs that relate to the treatment of disc/spine disease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:BRTX)

BioRestorative Therapies (NASDAQ:BRTX) Announces Commercial Agreement With Cartessa, Further Expanding Into $75.46 Billion Aesthetics Market

Accesswire 3 days ago

BioRestorative Therapies Provides First Quarter 2024 Business Update

GlobeNewswire 4 days ago

BioRestorative Therapies Enhances Preclinical Metabolic Program with a Novel Exosome-Based Biologic Targeting Obesity

GlobeNewswire 10 days ago

BioRestorative Therapies to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

GlobeNewswire April 30, 2024

BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology

GlobeNewswire April 30, 2024

BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment

GlobeNewswire April 16, 2024

BioRestorative Therapies Partners with Galen Patient Recruitment to Accelerate Completion of Enrollment in Phase 2 Trial of BRTX-100 in Chronic Lumbar Disc Disease

GlobeNewswire April 8, 2024

BioRestorative Therapies Announces Filing of Form S-1 Registration Statement to Register for Resale Common Stock Underlying Previously Issued Warrants

GlobeNewswire April 3, 2024

BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K

GlobeNewswire April 1, 2024
View More News ››

Opinion & Analysis (NDAQ:BRTX)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:BRTX)

BioRestorative Therapies Announces Exercise of Warrants and

BREAKING NEWS: $BRTX BioRestorative Therapies Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $8...
whytestocks - February 6, 2024

BioRestorative Therapies Presents Preliminary Clinical Data

Just In: $BRTX BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease...
whytestocks - February 5, 2024

BioRestorative Therapies to Present Preliminary BRTX-100 Cli

JUST IN: $BRTX BioRestorative Therapies to Present Preliminary BRTX-100 Clinical Data at the Orthopaedic Research Society (ORS) 2024...
whytestocks - February 1, 2024

BRTX ..... On watch

NR this a.m
Iseneschal - March 2, 2023

good news in court, so I bought some today

gains
Gonzoboardz - September 22, 2020

RE:BRTX phase 2 trails

https://eightbagger.wordpress.com/2018/08/03/big-gains-for-stocks-in-the-cbd-and-biotech-market/
Kevelle - August 10, 2018
View more Bullboard ››

Emperor Metals Inc.

Emperor Metals Inc.

Emperor Metals Inc. is a Canadian mineral exploration company focused on developing gold properties situated in the Canadian ...
View More »